Publicaciones en las que colabora con Josefa Salgado Garrido (12)

2015

  1. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer

    Mitochondrial DNA, Vol. 26, Núm. 2, pp. 227-231

2013

  1. KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients

    Oncology Letters, Vol. 6, Núm. 5, pp. 1343-1345

2011

  1. A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation

    Oncology Letters, Vol. 2, Núm. 5, pp. 807-809

2010

  1. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family

    Breast Cancer Research and Treatment, Vol. 121, Núm. 1, pp. 219-220

  2. Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 291-293

2009

  1. A novel BRCA1 mutation in a Spanish patient with ovarian cancer

    Breast Cancer Research and Treatment, Vol. 113, Núm. 1, pp. 71-73

2008

  1. A characterization of genetic haplotypes in BRCA1 identifies linkage disequilibrium with a novel polymorphism in intron 7

    Gene Therapy and Molecular Biology, Vol. 12, Núm. 2, pp. 175-180

  2. Review: Mitochondrial defects in breast cancer

    Clinical Medicine: Oncology, Vol. 2, pp. 199-207

2007

  1. GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment

    Current Drug Metabolism, Vol. 8, Núm. 5, pp. 481-486

  2. Oncogenes y genes supresores en cáncer

    Arán

  3. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

    Oncology Reports, Vol. 17, Núm. 2, pp. 325-328

2005

  1. Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population

    Oncology Reports, Vol. 14, Núm. 1, pp. 85-88